NO20084525L - Farmasoytiske sammensetninger inneholdende NMB0606-protein - Google Patents

Farmasoytiske sammensetninger inneholdende NMB0606-protein

Info

Publication number
NO20084525L
NO20084525L NO20084525A NO20084525A NO20084525L NO 20084525 L NO20084525 L NO 20084525L NO 20084525 A NO20084525 A NO 20084525A NO 20084525 A NO20084525 A NO 20084525A NO 20084525 L NO20084525 L NO 20084525L
Authority
NO
Norway
Prior art keywords
composition
present
nmb0606 protein
nmb0606
protein
Prior art date
Application number
NO20084525A
Other languages
English (en)
Inventor
Sonia Gonzalez Blanco
Rolando Pajon Feyt
Yasser Perera Negrin
Gretel Sardinas Garcia
Darien Garcia Diaz
Karem Cobas Acosta
Original Assignee
Ct Ingenieria Genetica Biotech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ct Ingenieria Genetica Biotech filed Critical Ct Ingenieria Genetica Biotech
Publication of NO20084525L publication Critical patent/NO20084525L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
    • Y10T436/143333—Saccharide [e.g., DNA, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Foreliggende oppfinnelse angår området medisin og spesielt utviklingen av en farmasøytisk sammensetning inneholdende NMB0606-proteinet. Sammensetningen ifølge foreliggende oppfinnelse gir beskyttelse mot forskjellige sykdommer som kan eller ikke kan være forårsaket av patogener. NMB0606-protein ble identifisert som en komponent av Neisseria meningitidis yttermenbranvesikkel (OMV) preparater og den ble oppnådd ved å bruke rekombinant deoksyribonukleinsyre (DNA) -teknologi. Dens immunogenitet og beskyttende aktivitet ble evaluert i dyremodeller. Grunnet det høye konserveringsnivå av genet som koder for NMB0606-proteinet, er sammensetningen omfattende dette av stor verdi som et antigen som induserer en bred reaktiv immunrespons. Sammensetningen ifølge foreliggende oppfinnelse kan anvendes innen humanmedisin.
NO20084525A 2006-03-31 2008-10-28 Farmasoytiske sammensetninger inneholdende NMB0606-protein NO20084525L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CU20060075A CU23575A1 (es) 2006-03-31 2006-03-31 Composición farmacéutica que comprende la proteína nmb0606
PCT/CU2007/000013 WO2007112703A2 (es) 2006-03-31 2007-03-29 Composición farmacéutica que comprende la proteína nmb0606

Publications (1)

Publication Number Publication Date
NO20084525L true NO20084525L (no) 2008-11-28

Family

ID=38535626

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20084525A NO20084525L (no) 2006-03-31 2008-10-28 Farmasoytiske sammensetninger inneholdende NMB0606-protein

Country Status (13)

Country Link
US (1) US20100129387A1 (no)
EP (1) EP2011509A2 (no)
KR (1) KR20080108576A (no)
CN (1) CN101448518A (no)
AR (1) AR060797A1 (no)
AU (1) AU2007234214A1 (no)
BR (1) BRPI0709922A2 (no)
CA (1) CA2647465A1 (no)
CU (1) CU23575A1 (no)
MX (1) MX2008012665A (no)
NO (1) NO20084525L (no)
WO (1) WO2007112703A2 (no)
ZA (1) ZA200808768B (no)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2019002489A (es) 2016-09-02 2019-10-21 Sanofi Pasteur Inc Vacuna contra neisseria meningitidis.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2270174A1 (en) * 1999-05-19 2011-01-05 Novartis Vaccines and Diagnostics S.r.l. Combination neisserial compositions
GB0103424D0 (en) * 2001-02-12 2001-03-28 Chiron Spa Gonococcus proteins
CU23236A1 (es) * 2003-12-03 2007-09-26 Ct Ingenieria Genetica Biotech PROTEINA NMB0928 Y SU USO EN FORMULACIONES FARMACéUTICAS P

Also Published As

Publication number Publication date
US20100129387A1 (en) 2010-05-27
AU2007234214A1 (en) 2007-10-11
MX2008012665A (es) 2008-10-13
BRPI0709922A2 (pt) 2011-07-26
WO2007112703A2 (es) 2007-10-11
AR060797A1 (es) 2008-07-16
CA2647465A1 (en) 2007-10-11
CN101448518A (zh) 2009-06-03
CU23575A1 (es) 2010-09-30
KR20080108576A (ko) 2008-12-15
EP2011509A2 (en) 2009-01-07
ZA200808768B (en) 2009-07-29
WO2007112703A3 (es) 2008-04-24

Similar Documents

Publication Publication Date Title
Olsen et al. Porphyromonas gingivalis disturbs host–commensal homeostasis by changing complement function
NO20045521L (no) Diarylureaderivater anvendelige for behandling av proteinkinaseavhengige sykdommer
WO2008079372A3 (en) Novel immunogenic compositions for the prevention and treatment of meningococcal disease
WO2007149715A3 (en) Novel dna sequences, vectors and proteins of avian influenza hemagglutinin
Süntar et al. Regulatory role of Nrf2 signaling pathway in wound healing process
NZ601538A (en) Vaccine compositions comprising a mutated factor h binding protein
NO20073868L (no) Levende attenuert rotavirus vaksine for oral administrering
CO7010783A2 (es) Proteína naglu humana recombinante y usos de la misma
NO20064584L (no) Tetrahydropyridoindolderivater
Nguyen et al. Arthritogenic alphavirus vaccines: serogrouping versus cross-protection in mouse models
Rajapaksha et al. Update on new aspects of the renin-angiotensin system in hepatic fibrosis and portal hypertension: implications for novel therapeutic options
WO2009009759A3 (en) Yersinia pestis antigens, vaccine compositions, and related methods
CY1113693T1 (el) Φαρμακευτικες συνθεσεις και μεθοδοι για τον εμβολιασμο κατα της διαχυτης καντιντιασης και αλλων μολυσματικων παραγοντων
MD4481B1 (ro) Herpesvirus recombinant Koi (KHV) şi vaccin pentru profilaxia bolii cauzate de KHV
Kennedy et al. A vaccine based on recombinant modified Vaccinia Ankara containing the nucleoprotein from Lassa virus protects against disease progression in a guinea pig model
González-Pech et al. Transcriptomic resilience of the Montipora digitata holobiont to low pH
NO20084525L (no) Farmasoytiske sammensetninger inneholdende NMB0606-protein
BRPI0818957B8 (pt) gene isolado, vetor de expressão, célula hospedeira geneticamente modificada e método para preparação de uma macromolécula imunogênica
NO20084524L (no) Farmasoytisk sammensetning inneholdende NMB0938-protein
NO20051561L (no) Nukleinsyremolekyler som koder for humant papillomavirus og anvendelse av disse i vaksine.
Yoon et al. Macrophage-derived insulin-like growth factor-1 affects influenza vaccine efficacy through the regulation of immune cell homeostasis
NO20063017L (no) Protein NMB0928 og anvendelse derav i farmasoytiske formuleringer
WO2010039924A3 (en) Th1 vaccination priming for active immunotheraphy
BR112014007491A2 (pt) sequências de aminoácidos para o controle de patógenos
WO2009077744A3 (en) Vaccines for brucellosis

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application